A retrospective review of Botulinum toxin type A compared with standard therapy in the treatment of lumbar myofascial back pain patients

Pain Clinic

Volumn 15, Issue 3, 2003, Pages 205-211

  Carrasco, Arnulfo T ^a   Wescoat, Laurie ^a   Roman, Angel ^a  

^a Texas Neurosciences Institute   (United States)

Author keywords

Botox ; Botulinum toxin type A; Low back pain; Myofascial pain

Indexed keywords

ANESTHETIC AGENT; BOTULINUM TOXIN A; BUPIVACAINE; MUSCLE RELAXANT AGENT; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; TRIAMCINOLONE ACETONIDE;

ADULT; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTROMYOGRAM; FEMALE; FLU LIKE SYNDROME; GLUTEUS MAXIMUS MUSCLE; HUMAN; INTERMETHOD COMPARISON; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MYOFASCIAL PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 0141569058     PISSN: 01691112     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856903767650709     Document Type: Review

References (14)

1. Roncarati A, McMullin W, Correlates of low back pain in a general population sample: a multidisciplinary perspective, J Manipulative Physiol Ther 11, 158-64 (1988).
2. Gerwin RD, Classification, epidemiology, and natural history of myofascial pain syndrome, Curr Pain Headache Rep 5, 412-20 (2001).
3. Porta M, A comparative trial of Botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm, Pain 85, 101-5 (2000).
4. Cheshire WP, Abashian SW, Mann JD, Botulinum toxin in the treatment of myofascial syndrome, Pain 59, 65-9 (1994).
5. Comella CL, Jankovic J, Brin MF, Use of Botulinum toxin type A in the treatment of cervical dystonia, Neurology 55 (12, Suppl. 5), S 15-S21 (2000).
6. Price DD, Bush FM, Long S, et al., A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales, Pain 56, 217-26 (1994).
7. Margolis RB, A rating system for use with patient pain drawings, Pain 24, 57-65 (1986).
8. Foster L, Clapp L, Erickson M, Jabbari B, Botulinum toxin A and chronic low back pain, Neurology 56, 1290-8 (2001).
9. Freund BJ, Schwartz M, Treatment of whiplash associated with neck pain with Botulinum toxin-A: a pilot study, J Rheumatol 27, 481-4 (2000).
10. Barwood S, Ballieu C, Boyd R, et al., Analgesic effects of Botulinum toxin A: a randomized, placebo-controlled clinical trial, Dev Med Child Neurol 42, 116-21 (2000).
11. Mam MK, Results of epidural injection of local anesthetic and corticosteroid in patients with lumbosciatic pain, J Indian Med Assoc 93, 17-8, 24 (1995, Jan).
12. Ringe JD, Coster A, Meng T, Schacht E, Umbach R, Therapy of glucocorticoid-induced osteoporosis with alfacalcidol/calcium and vitamin D/calcium, Z Rheumatol 59, 176-82 (2000).
13. Sato T, Takahashi K, Okuma Y, et al., A senile case of acute necrotizing myopathy presenting prolonged severe muscle paralysis due to high dose glucocorticoid and muscle relaxant, Nippon Ronen Igakkai Zasshi 37, 250-4 (2000).
14. Wissel J, Muller J, Dressnandt J, et al., Management of spasticity associated pain with Botulinum toxin A, J Pain Symptom Manage 20, 44-9 (2000).